phe885,tocilizumab
jw pharma,novartis,roche
['mmsm', 'tocilizumab', 'phe885', 'toci']
great presentation by on phe885 car t-cell therapy.
vein-to-vein 16 days: aiming for &lt;10d! 33% emd; 36% hr cyto
98% orr, w/responses deepening w/time.
mrd-neg @ 6 months 14/19 (74%)
crs rates high but low grade given high rates of tocilizumab. #mmsm #asco23 
Asst Professor at University of Chicago, specializing in (vanquishing) plasma cell disorders. I tweet about: Myeloma & MRD. https://t.co/mPeWg1QRrW